Latest Breaking News On - World congress on gastrointestinal cancer - Page 4 : comparemela.com

RenovoRx (RNXT) Announces New Positive Interim Phase III Data Demonstrating RenovoGem Delays Cancer Progression by Eight Months in Locally Advanced Pancreatic Cancer

RenovoRx (RNXT) Announces New Positive Interim Phase III Data Demonstrating RenovoGem Delays Cancer Progression by Eight Months in Locally Advanced Pancreatic Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMichaelj pishvaianShaun bagaiJack perkinsStrategic communicationsRenovorx incExchange commissionWorld congress on gastrointestinal cancerTiger pac data monitoring committeeSecurities exchangeAmerican cancer society facts figuresGastrointestinal cancerJohns hopkins medicinePrincipal investigatorR pac data monitoring committeeTrans arterial micro perfusion

Microcap Biotech Stock RenovoRx is Shooting Higher Today: Here s Why - RenovoRx (NASDAQ:RNXT)

RenovoRx Inc (NASDAQ: RNXT) presented new data on progression-free survival (PFS) from the pivotal Phase 3 open-label TIGeR-PaC study of RenovoGem (intra-arterial administration of gemcitabine) in locally 

Renovorx incWorld congress on gastrointestinal cancerTiger pac data monitoring committeeR pac data monitoring committee

AstraZeneca (AZN) Announces IMFINZI plus IMJUDO demonstrated sustained OS benefit in advanced liver cancer

AstraZeneca (AZN) Announces IMFINZI plus IMJUDO demonstrated sustained OS benefit in advanced liver cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Comunidad autonoma de catalunaUnited statesSusan galbraithBruno sangroImfinziand imjudoinWorld congress on gastrointestinal cancerEuropean society for medical oncologyMedical oncologyWorld congressGastrointestinal cancerSingle tremelimumab regular interval durvalumabLiver unitInternal medicineUniversidad de navarraExecutive vice presidentFatal immune mediated adverse

RenovoRx Announces New Positive Interim Phase III Data Demonstrating RenovoGem™ Delays Cancer Progression by Eight Months in Locally Advanced Pancreatic Cancer

RenovoRx Announces New Positive Interim Phase III Data Demonstrating RenovoGem™ Delays Cancer Progression by Eight Months in Locally Advanced Pancreatic Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesShaun bagaiMichaelj pishvaianJack perkinsRenovorx incSecurities exchangeTiger pac data monitoring committeeStrategic communicationsAmerican cancer society facts figuresExchange commissionCompany nasdaqWorld congress on gastrointestinal cancerSix month overall survival benefitLocally advanced pancreaticGastrointestinal cancerJohns hopkins medicine

RenovoRx encountering a lot of enthusiasm for innovative cancer platform

RenovoRx Inc (NASDAQ:RNXT) CEO Shaun Bagai speaks to Thomas Warner during a visit to Europe to present at the ESMO World Congress on Gastrointestinal Cancer.

Comunidad autonoma de catalunaThomas warnerShaun bagaiRenovorx incWorld congress on gastrointestinal cancerGastrointestinal cancer